Biomedical engineer and co‑founder of Avectas leading the development and commercialisation of the Solupore® platform.
Veteran life sciences executive with extensive experience in business development, alliance management and corporate strategy.
Chartered accountant leading finance, strategic planning and operations across Avectas.
Senior investment professional and board leader with experience across venture capital, corporate finance and biotech governance.
Biotech executive and board member bringing strategic guidance and governance experience.
Seasoned biopharma leader and board director with deep R&D and corporate leadership expertise.
Barbara & Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania, pioneer in CAR‑T development.
Immunologist and cell therapy pioneer with extensive GMP and potency analytics expertise.
Clinician‑scientist in immuno‑oncology and engineered immune cells, advising on clinical strategy and cell phenotype.
Senior bioprocessing executive formerly with Biogen and the Bill & Melinda Gates Foundation; advises on industrialisation and global supply chain strategy.
Cell and gene therapy expert with senior roles at UPenn, bluebird bio and ElevateBio; advises on translational development and partnering.